Home › Steatotic Liver Disease › Missouri › St. Louis
Pag-aaral pangklinika para sa Steatotic Liver Disease sa St. Louis, MO
9 pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng St. Louis (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Nagre-recruitPhase 3
- 89bio Clinical Study Site, St Louis
- 89bio Clinical Study Site, St Louis
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Nagre-recruitPhase 3
- 89bio Clinical Study Site, St Louis
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Nagre-recruitPhase 3
- GSK Investigational Site, St Louis
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Nagre-recruitPhase 3
- GSK Investigational Site, St Louis
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Nagre-recruitPhase 2
- Washington University School of Medicine, St Louis
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Nagre-recruitPhase 3
- Akero Clinical Study Site, St Louis
- Akero Clinical Study Site, St Louis
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Nagre-recruitPhase 3
- GSK Investigational Site, St Louis
- GSK Investigational Site, St Louis
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Nagre-recruitPhase 2
- Gateway GI Research, LLC, St Louis
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Nagre-recruitPhase 3
- GSK Investigational Site, St Louis
Pag-aaral para sa Steatotic Liver Disease sa ibang lungsod
- San Antonio, TX17 pag-aaral
- New York City, NY16 pag-aaral
- Miami, FL16 pag-aaral
- San Diego, CA14 pag-aaral
- Austin, TX13 pag-aaral
- Houston, TX13 pag-aaral
- Richmond, VA12 pag-aaral
- Chandler, AZ10 pag-aaral
- Tucson, AZ10 pag-aaral
- Orlando, FL9 pag-aaral
- Dallas, TX9 pag-aaral
- Hialeah, FL9 pag-aaral
Iba pang pag-aaral sa St. Louis
- Non-Small Cell Lung Cancer73 pag-aaral
- Kanser sa Suso64 pag-aaral
- Metastatic Cancer54 pag-aaral
- Colorectal Cancer50 pag-aaral
- Kanser (lahat ng uri)46 pag-aaral
- Kanser sa Prostate46 pag-aaral
- Kanser sa Baga39 pag-aaral
- Kanser sa Ovary38 pag-aaral
- Kanser sa Pancreas33 pag-aaral
- Kanser ng Endometrium29 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg28 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.